THE FUTURE OF SIRNA Trademark

Trademark Overview

On Wednesday, April 16, 2008, a trademark application was filed for THE FUTURE OF SIRNA with the United States Patent and Trademark Office. The USPTO has given the THE FUTURE OF SIRNA trademark a serial number of 77450053. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 16, 2012. This trademark is owned by ZaBeCor Pharmaceutical Company, LLC. The THE FUTURE OF SIRNA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-inflammatories; pain relief medications
the future of sirna

General Information

Serial Number77450053
Word MarkTHE FUTURE OF SIRNA
Filing DateWednesday, April 16, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 16, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 23, 2008

Trademark Statements

Goods and ServicesAnti-inflammatories; pain relief medications

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 21, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZABECOR PHARMACEUTICALS, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBala Cynwyd, PA 19004
Party NameZABECOR PHARMACEUTICALS, LLC
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressPHILADELPHIA, PA 19119
Party NameZaBeCor Pharmaceutical Company, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPhiladelphia, PA 19119

Trademark Events

Event DateEvent Description
Thursday, February 2, 2012UNDELIVERABLE MAIL - NO ACTION TAKEN
Tuesday, January 17, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 16, 2012ABANDONMENT - NO USE STATEMENT FILED
Friday, June 17, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 16, 2011EXTENSION 5 GRANTED
Thursday, June 9, 2011EXTENSION 5 FILED
Thursday, June 9, 2011TEAS EXTENSION RECEIVED
Friday, January 14, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 13, 2011EXTENSION 4 GRANTED
Wednesday, December 15, 2010EXTENSION 4 FILED
Wednesday, December 15, 2010TEAS EXTENSION RECEIVED
Tuesday, June 22, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 21, 2010EXTENSION 3 GRANTED
Friday, June 11, 2010EXTENSION 3 FILED
Friday, June 11, 2010TEAS EXTENSION RECEIVED
Monday, January 4, 2010EXTENSION 2 GRANTED
Monday, December 14, 2009EXTENSION 2 FILED
Monday, December 14, 2009TEAS EXTENSION RECEIVED
Friday, July 17, 2009EXTENSION 1 GRANTED
Tuesday, June 16, 2009EXTENSION 1 FILED
Friday, July 17, 2009DIVISIONAL PROCESSING COMPLETE
Tuesday, June 16, 2009DIVISIONAL REQUEST RECEIVED
Thursday, July 16, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 16, 2009TEAS EXTENSION RECEIVED
Tuesday, June 16, 2009TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, December 16, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 30, 2008ASSIGNED TO EXAMINER
Tuesday, September 23, 2008PUBLISHED FOR OPPOSITION
Wednesday, September 3, 2008NOTICE OF PUBLICATION
Saturday, August 16, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, August 16, 2008ASSIGNED TO LIE
Monday, August 11, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 29, 2008ASSIGNED TO EXAMINER
Wednesday, July 23, 2008AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, April 21, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

sirna future medications relief pain inflammatories anti